Literature DB >> 8840968

Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers.

S L Lu1, W C Zhang, Y Akiyama, T Nomizu, Y Yuasa.   

Abstract

To characterize the tumorigenetic role of the transforming growth factor beta type II receptor (RII) gene, we defined its genomic structure, which consists of seven exons. The sequences of exon-intron junctions were determined to facilitate mutation analysis of each exon. Twenty-five carcinomas and five adenomas from hereditary nonpolyposis colorectal cancer patients were analyzed for mutations in the entire coding region. Four missense mutations (two in adenomas and two in carcinomas) were found in the 10 cases carrying the polyadenine deletions in one allele. These results indicate that RII shares the two-hit inactivation mechanism with tumor suppressor genes and that mutations of it may occur in the early stage of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840968

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.

Authors:  M Toyota; M Ohe-Toyota; N Ahuja; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma.

Authors:  Huafeng Wei; Pu Liu; Elizabeth Swisher; Yuen Yee Yip; Jee Hang Tse; Kathy Agnew; Karl Erik Hellström; Ingegerd Hellström
Journal:  J Immunother       Date:  2012-04       Impact factor: 4.456

3.  Establishment and characterization of six human gastric carcinoma cell lines, including one naturally infected with Epstein-Barr virus.

Authors:  Ja-Lok Ku; Kyung-Hee Kim; Jin-Sung Choi; Sung-Hee Kim; Young-Kyoung Shin; Hee Jin Chang; Jae-Moon Bae; Young-Woo Kim; Jun Ho Lee; Han-Kwang Yang; Woo-Ho Kim; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Cell Oncol (Dordr)       Date:  2012-02-24       Impact factor: 6.730

4.  Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer.

Authors:  A J Alvi; J S Rader; M Broggini; F Latif; E R Maher
Journal:  Mol Pathol       Date:  2001-08

5.  Mechanism for mutational inactivation of the tumor suppressor Smad2.

Authors:  C Prunier; N Ferrand; B Frottier; M Pessah; A Atfi
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

6.  Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas.

Authors:  S R Amoroso; N Huang; A B Roberts; M Potter; J J Letterio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

7.  Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.

Authors:  T A McCaffrey; B Du; S Consigli; P Szabo; P J Bray; L Hartner; B B Weksler; T A Sanborn; G Bergman; H L Bush
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

8.  Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer.

Authors:  E Lucci-Cordisco; V Rovella; S Carrara; A Percesepe; M Pedroni; A Bellacosa; O Caluseriu; M Forasarig; M Anti; G Neri; M Ponz de Leon; A Viel; M Genuardi
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

Review 9.  The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes.

Authors:  C Oliveira; R Seruca; M Seixas; M Sobrinho-Simões
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

Review 10.  Roles of Smad3 in TGF-beta signaling during carcinogenesis.

Authors:  Caroline Millet; Ying E Zhang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.